Loading...
Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases
PURPOSE: Intravenous (IVIG) and subcutaneous (SCIG) immunoglobulin infusions are widely used for the treatment of patients with primary immunodeficiency (PID) worldwide. This prospective, multicenter, open-label, single-arm Phase III study evaluated the efficacy, tolerability, and safety of IgPro20...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer US
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3937544/ https://ncbi.nlm.nih.gov/pubmed/24504846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10875-013-9985-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|